E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression

Post time 3 day(s) ago

journal：Gut

Authors：Zerui Zhang; Wenjie Huang; Dian Hu; Junqing Jiang; Jiaqian Zhang; Zhangfan Wu; Junjie Wen; Xiangyuan Luo; Yijun Wang; Mengyu Sun; Siwen Li; Yufei Wang; Danfei Liu; Xiaoping Chen; Bixiang Zhang; Huifang Liang; Yiwei Li; Bifeng Liu; Shuai Wang; Xiao Xu; Yongzhan Nie; Kaichun Wu; Daiming Fan; Limin Xia

Published date：2025-7-

DOI：10.1136/gutjnl-2024-333944

PDF link：https://syndication.highwire.org ... /gutjnl-2024-333944

Article link：https://doi.org/10.1136/gutjnl-2024-333944

Article Source：BMJ。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[BMJ] E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[BMJ] E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[BMJ] E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression